In our previous study using a dietary NASH mouse model, we found that treatment with FTY720, an S1P1, 3, 4, 5 functional antagonist, ameliorates the cardinal features of NASH (10). Here, S1PR1 is linked to metabolic dysfunction-associated steatohepatitis.